Department of Managed Health Care Issues Prescription Drug Cost Transparency Report for Measurement Year 2020

By Hunter W. Collins On December 27, 2021, the Department of Managed Health Care (DMHC) released its Prescription Drug Cost Transparency Report for Measurement Year 2020. Pursuant to SB 17 (Hernandez) (Chapter 603, Statutes of 2017), Health and Safety Code Continue reading

Department of Managed Health Care Issues Prescription Drug Cost Transparency Report for Measurement Year 2019

By Meena Kaypour On December 30, 2020, the Department of Managed Health Care (DMHC) released its Prescription Drug Cost Transparency Report for Measurement Year 2019. Pursuant to SB 17 (Hernandez) (Chapter 603, Statutes of 2017), Health and Safety Code section Continue reading

Federal Judge Upholds Legality of Drug Transparency Law Requiring Manufacturers to Report Drug Price Increases to Department of Insurance

By Hannah Ohman On January 4, 2021, the United States District Court for the Eastern District of California filed an order upholding the legality of a 2017 California drug price transparency law in Pharmaceutical Research & Manufacturers of America (“PhRMA”) Continue reading